Gandouling ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
171Wilson disease3

171. Wilson disease


Clinical trials : 79 Drugs : 77 - (DrugBank : 17) / Drug target genes : 6 - Drug target pathways : 30
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05305872
(ClinicalTrials.gov)
January 1, 202324/11/2021Gandouling in the Treatment of Wilson's DiseaseThe First Affiliated Hospital of Anhui University of Traditional Chinese MedicineWilson's DiseaseDrug: GandoulingJun LiNULLNot yet recruiting15 Years85 YearsAll216Phase 4NULL
2ITMCTR2100005333
2021-12-122021-11-26A multicenter, randomized controlled, double-blind and double simulated clinical evaluation of gandouling tablet in the treatment of Wilson's diseaseA multicenter, randomized controlled, double-blind and double simulated clinical evaluation of gandouling tablet in the treatment of patients with hepatolenticular degeneration Wilson's diasease2:Zinc gluconate;1:Gandouling;The First Affiliated Hospital of Anhui University of traditional Chinese MedicineNULLPending1585Both2:100;1:100;Phase 1China
3ChiCTR2100053629
2021-12-122021-11-26A multicenter, randomized controlled, double-blind and double simulated clinical evaluation of gandouling tablet in the treatment of Wilson's diseaseA multicenter, randomized controlled, double-blind and double simulated clinical evaluation of gandouling tablet in the treatment of patients with hepatolenticular degeneration Wilson's diseaseA group:Gandouling tablet + zinc gluconate simulator;B group:Zinc gluconate + gandouling tablet simulator;The First Affiliated Hospital of Anhui University of Traditional Chinese MedicineNULLPending15BothA group:100;B group:100;China